The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chechulova A.V.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Kapustin S.I.

Russian Research Institute of Hematology and Transfusion Medicine

Soroka V.V.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Soldatenkov V.E.

Russian Research Institute of Hematology and Transfusion Medicine

Kargin V.D.

Russian Research Institute of Hematology and Transfusion Medicine

Papayan L.P.

Russian Research Institute of Hematology and Transfusion Medicine

Malkova P.M.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Galchenko M.I.

HiQo Solutions LLC

Gene-Gene Interactions Between Some Plasma Hemostasis Factors in Patients with Early Venous Thromboembolism

Authors:

Chechulova A.V., Kapustin S.I., Soroka V.V., Soldatenkov V.E., Kargin V.D., Papayan L.P., Malkova P.M., Galchenko M.I.

More about the authors

Journal: Journal of Venous Disorders. 2021;15(1): 50‑56

DOI: 10.17116/flebo20211501150

Read: 1909 times

Download PDF (RU)
Contact the author
Table of contents

GENE-GENE INTERACTIONS BETWEEN SOME PLASMA HEMOSTASIS FACTORS IN PATIENTS WITH EARLY VENOUS THROMBOEMBOLISM
GENE-GENE INTERACTIONS BETWEEN SOME PLASMA HEMOSTASIS FACTORS IN PATIENTS WITH EARLY VENOUS THROMBOEMBOLISM

To cite this article:

Chechulova AV, Kapustin SI, Soroka VV, et al. . Gene-Gene Interactions Between Some Plasma Hemostasis Factors in Patients with Early Venous Thromboembolism. Journal of Venous Disorders. 2021;15(1):50‑56. (In Russ.)
https://doi.org/10.17116/flebo20211501150

Подписка 2026 Флебология (Journal of Venous Disorders)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Clinical and gene­tic asso­ciations in patients with non-cardioembolic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):12-19
Asplenia — a new cause of thro­mbosis in pregnant women?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):71-76
Socio-economic damage caused by elevated low-density lipo­protein cholesterol levels. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):88-98
Hemo­stasis diso­rders during neoadjuvant therapy in patients with breast cancer. P.A. Herzen Journal of Onco­logy. 2025;(3):39-44
Effi­cacy and Safety of the Oral Anti­coagulant DIMO­LEGIN Compared to Enoxaparin Sodium for the Prevention of Venous Thro­mboembolism Following Major Joint Replacement Surgery (hip or knee arthroplasty): A Randomized, Double-Blind, Multicenter Trial. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):577-585
Prevalence of low-functioning alle­les of folate cycle genes and their asso­ciation with cardiovascular pathology and a complicated obstetric history in the popu­lation of the Arkhangelsk Region. Labo­ratory Service. 2025;(3):8-13
Coro­naviruses in human pathophysiology: a brief history of the COVID-19 pandemic. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):55-63
Cere­bral venous thro­mbosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):36-42
Distal 18q dele­tion syndrome (18q-) in a pediatric patient. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):244-248
Abstract:

Venous thromboembolism (VTE) is a multifactorial disease with complex pathogenesis and polygenic inheritance.

OBJECTIVE

To determine the most common combinations of genes encoding the main plasma hemostasis factors in young patients with VTE.

MATERIAL AND METHODS

We examined 243 young patients (up to 45 years old) with deep vein thrombosis and/or pulmonary embolism. There were 119 men (48.9%) and 124 women (51.1%) aged 37.4 years (range 18-45). The control group consisted of 171 healthy people. All patients were genotyped for polymorphism of seven genes: FI-B -455 G/A, FII 20210 G/A, FV 1691 G/A, FXII 46 C/T, FXIII Val34Leu, PAI-1 -675 4G/5G, TPA 311 bp Ins/Del. Genetic variants were identified by PCR-RFLP method.

RESULTS

Mutations FV 1691 G/A (OR=2.9; p=0.006) and FII 20210 G/A (OR=8.8; p=0.001) were independent risk factors of VTE. In addition, the following combinations of genotypes were significantly more common: «FXIII 34Val/Leu + FI-B -455GA» (OR=2.3; p=0.007), «FXIII 34Val/Leu + PAI-1 4G/4G» (OR=2.1; p=0.013), and «FXIII 34Val/Leu + FXII 46CT» (OR=2.2; p=0.01). FXIII 34Val/Leu variant was independently associated with the risk of VTE in young women (OR=2.3; p=0.002).

CONCLUSION

In addition to mutations in the genes of factors II and V, Val34Leu polymorphism of factor XIII has a significant effect on the risk of VTE in young people. The last aspect is especially true for combination with carriage of unfavorable variants of FI-B, FXII or/and PAI-1 genes.

Keywords:

venous thromboembolism
thrombophilia
risk factor
gene
polymorphism
gene-gene associations

Authors:

Chechulova A.V.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Kapustin S.I.

Russian Research Institute of Hematology and Transfusion Medicine

Soroka V.V.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Soldatenkov V.E.

Russian Research Institute of Hematology and Transfusion Medicine

Kargin V.D.

Russian Research Institute of Hematology and Transfusion Medicine

Papayan L.P.

Russian Research Institute of Hematology and Transfusion Medicine

Malkova P.M.

Dzhanelidze St. Petersburg Research Institute for Emergency Care

Galchenko M.I.

HiQo Solutions LLC

Received:

08.11.2020

Accepted:

11.12.2020

Close metadata

References:

  1. Crous-Bou M, Harrington LB, Kabrhel C. Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. Semin Thromb Hemost. 2016;42(8):808-820.  https://doi.org/10.1055/s-0036-1592333
  2. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost. 2001;86(3):809-816. 
  3. Klarin D, Lynch J, Aragam K, Chaffin M, Assimes TL, Huang J, Lee KM, Shao Q, Huffman JE, Natarajan P, Arya S, Small A, Sun YV, Vujkovic M, Freiberg MS, Wang L, Chen J, Saleheen D, Lee JS, Miller DR, Reaven P, Alba PR, Patterson OV, DuVall SL, Boden WE, Beckman JA, Gaziano JM, Concato J, Rader DJ, Cho K, Chang KM, Wilson PWF, O’Donnell CJ, Kathiresan S; VA Million Veteran Program, Tsao PS, Damrauer SM. Genome-wide association study of peripheral artery disease in the Million Veteran Program. Nat Med. 2019;25(8):1274-1279. https://doi.org/10.1038/s41591-019-0492-5
  4. Lindström S, Wang L, Smith EN, Gordon W, van Hylckama Vlieg A, de Andrade M, Brody JA, Pattee JW, Haessler J, Brumpton BM, Chasman DI, Suchon P, Chen MH, Turman C, Germain M, Wiggins KL, MacDonald J, Braekkan SK, Armasu SM, Pankratz N, Jackson RD, Nielsen JB, Giulianini F, Puurunen MK, Ibrahim M, Heckbert SR, Damrauer SM, Natarajan P, Klarin D; Million Veteran Program, de Vries PS, Sabater-Lleal M, Huffman JE; CHARGE Hemostasis Working Group, Bammler TK, Frazer KA, McCauley BM, Taylor K, Pankow JS, Reiner AP, Gabrielsen ME, Deleuze JF, O’Donnell CJ, Kim J, McKnight B, Kraft P, Hansen JB, Rosendaal FR, Heit JA, Psaty BM, Tang W, Kooperberg C, Hveem K, Ridker PM, Morange PE, Johnson AD, Kabrhel C, Trégouët DA, Smith NL. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood. 2019;134(19):1645-1657. https://doi.org/10.1182/blood.2019000435
  5. Rosendaal FR, Vessey M, Rumley A, Daly E, Woodward M, Helmerhorst FM, Lowe GD. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol. 2002;116(4): 851-854.  https://doi.org/10.1046/j.0007-1048.2002.03356.x
  6. Undas A. Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence. Biomed Res Int. 2017;2017:8196256. https://doi.org/10.1155/2017/8196256
  7. Wolberg AS. Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition. Curr Opin Hematol. 2018;25(5):358-364.  https://doi.org/10.1097/MOH.0000000000000445
  8. Aleman MM, Walton BL, Byrnes JR, Wolberg AS. Fibrinogen and red blood cells in venous thrombosis. Thromb Res. 2014;133(Suppl 1):38-40.  https://doi.org/10.1016/j.thromres.2014.03.017
  9. Chandrashekar A, Singh G, Jonah Garry, Sikalas N, Labropoulos N. Mechanical and Biochemical Role of Fibrin Within a Venous Thrombus. Eur J Vasc Endovasc Surg. 2018;55(3):417-424.  https://doi.org/10.1016/j.ejvs.2017.12.002
  10. Undas A, Zawilska K, Ciesla-Dul M, Lehmann-Kopydłowska A, Skubiszak A, Ciepłuch K, Tracz W. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood. 2009;114(19):4272-4278. https://doi.org/10.1182/blood-2009-05-222380
  11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. https://doi.org/10.1093/nar/16.3.1215
  12. Berthold MR, Cebron N, Dill F, Gabriel TR, Kötter T, Meinl T, Ohl P, Sieb C, Thiel K, Wiswedel B. KNIME: The Konstanz Information Miner. In: Preisach C, Burkhardt H, Schmidt-Thieme L, Decker R (eds). Data Analysis, Machine Learning and Applications. Studies in Classification, Data Analysis, and Knowledge Organization. Berlin, Heidelberg: Springer; 2008. https://doi.org/10.1007/978-3-540-78246-9_38
  13. Webb GI. Decision tree grafting from the all-tests-but-one partition, Proc. Sixteenth Int. Joint Conf. Artificial Intelligence (IJCAI’99). Machine Learning. 1999;2:702-707. 
  14. Frank E, Witten IH. Generating Accurate Rule Sets Without Global Optimization. In: Fifteenth International Conference on Machine Learning. San Francisco: Morgan Kaufmann Publishers Inc.; 1998.
  15. Brent M. Instance-based learning: Nearest neighbor with generalization. Master’s thesis. Hamilton, New Zealand: University of Waikato; 1995.
  16. Borgelt C. Frequent item set mining. Wiley Interdiscip Rev Data Min Knowl Discov. 2012;2(6):437-456.  https://doi.org/10.1002/widm.1074
  17. Asif M, Martiniano HFMCM, Vicente AM, Couto FM. Identifying disease genes using machine learning and gene functional similarities, assessed through Gene Ontology. PLoS One. 2018;13(12):e0208626.
  18. Hirmerova J, Seidlerova J, Subrt I. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox. QJM. 2014;107(9):715-720.  https://doi.org/10.1093/qjmed/hcu055
  19. Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000;96(3):988-995. 
  20. Demyanenko AV, Kapustin SI, Soroka VV, Chechulov PV. Allelic polymorphism of genes associated with hemostatic system activity and the risk of venous thromboembolism in young patients. Medical Genetics. 2015;14(12):33-38. (In Russ.).
  21. Jern C, Ladenvall P, Wall U, Jern S. Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arterioscler Thromb Vasc Biol. 1999;19(2):454-459.  https://doi.org/10.1161/01.atv.19.2.454
  22. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet. 1994;343(8903):940-943.  https://doi.org/10.1016/s0140-6736(94)90064-7
  23. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332(10):635-641.  https://doi.org/10.1056/NEJM199503093321003
  24. Hooper WC, El-Jamil M, Dilley A, Philipp C, Ellingsen D, Phillips D, Evatt BL. The relationship between the tissue plasminogen activator Alu I/D polymorphism and venous thromboembolism during pregnancy. Thromb Res. 2001;102(1):33-37.  https://doi.org/10.1016/s0049-3848(01)00220-1
  25. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y. A common genetic polymorphism (46 C to T substitution) in the 5’-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood. 1998;91(6):2010-2014.
  26. Cochery-Nouvellon E, Mercier E, Lissalde-Lavigne G, Daurès JP, Quéré I, Dauzat M, Marès P, Gris JC. Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy. J Thromb Haemost. 2007;5(4):700-707.  https://doi.org/10.1111/j.1538-7836.2007.02423.x
  27. Huang G, Wang P, Li T, Deng X. Genetic association between plasminogen activator inhibitor-1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta-analysis. Clin Cardiol. 2019;42(12):1232-1238. https://doi.org/10.1002/clc.23282
  28. Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J, Xu M. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism — a meta-analysis and systematic review. Vasa. 2020;49(2):141-146.  https://doi.org/10.1024/0301-1526/a000839
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.